KANSAS CITY, Kan., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cingulate's technology will let ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results